Bionovo, Inc. (Nasdaq: BNVI), a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, announced that enrollment has started to the Phase 3 pivotal clinical trial evaluating the safety and efficacy of two doses of Menerba™...
There's a guy I am dating who hardly ever initiates dates. There has been a couple of times, but I feel like I do it more. He does call and text me first about 90% of the time, so I'll give him that. I know he's a bit shy, but around me, this guy can talk up a storm.
Should I keep initiating...
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced that it has initiated a Phase 1 clinical study for ISIS-PTP1BRx, an antisense drug for the treatment of type 2 diabetes targeting protein tyrosine phosphatase-1B, PTP-1B. ISIS-PTP1BRx is designed to increase the body's sensitivity to the...
InterMune (NASDAQ: ITMN) announced that patient enrollment has begun in ASCEND, a new Phase 3 study of pirfenidone for patients who suffer from idiopathic pulmonary fibrosis (IPF). ASCEND is a multinational, randomized, double-blind, placebo controlled Phase 3 trial designed to evaluate the...
Palatin Technologies, Inc. (NYSE Amex: PTN) announced that enrollment of patients has commenced in Palatin's Phase 2b clinical trial evaluating the efficacy and safety of bremelanotide (previously called PT-141), an on-demand, first-in-class melanocortin agonist being developed for the treatment...
Diamyd Medical AB (STO:DIAMB)(Pink Sheets:DMYDY) reports that the Company has decided to suspend dosing in a US Phase III study with the antigen-based therapy Diamyd® and to initiate closure of the study. Following consultation with the US Food and Drug Administration (FDA), Diamyd Medical has...
almost always interested? *I've known him since late January
*They aren't stupid "hey what's up" texts--they are funny inside jokes usually
*He's 21 and I'm 20
Do guys text girls for the hell of it or is it because they like her?
*I asked him to call me to help me with some math questions and...
Evolva Holding SA (SIX: EVE), announced it has initiated a multiple ascending dose Phase I clinical study with an extended release oral formulation of EV-077. An earlier first-in-man single ascending dose study with an oral solution of EV-077 indicated that it was a potent, fast-acting and...
...then shes interested? Two hot girls randomly initiated a convo with me in ONE week and i dont even really know them. I mean it made me feel proud because im super shy so i rarely even talk to mediocre girls. Im sure its not that big of a deal but still it boosts my confidence a lot. But even...
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced the initiation of dosing in a Phase 1 clinical trial of APD811, a novel oral drug candidate discovered by Arena that targets the prostacyclin receptor for the treatment of pulmonary arterial hypertension, or PAH. "An orally bioavailable...
Uroplasty, Inc. (Nasdaq: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, announced that Palmetto GBA for California, Nevada and Hawaii, a regional Medicare carrier, now covers posterior tibial nerve stimulation...
NephRx Corporation announced that it has initiated a Phase I clinical trial of its lead compound NX001 and has successfully dosed the first subject in the study. NX001, a kidney growth factor peptide that has demonstrated good safety and promising efficacy in two animal models of acute renal...
Hey guys, thanks for helping me!
I have a great boyfriend, but he rarely initiates physical activity! When I kiss him and start touching him he gladly reciprocates, but he rarely is the first to touch me. This makes me sad because I love sex and I want to know he desires me.
I sent him a...
Relypsa, Inc., announced the initiation of patient enrollment in a Phase 2, open-label titration clinical study of the company's lead drug candidate, RLY5016, in heart failure patients with chronic kidney disease. RLY5016 is a novel non-absorbed oral potassium binder intended to prevent and...
Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced that it has initiated a Phase 1 study of ISIS-SOD1Rx in patients with an inherited, aggressive form of Lou Gehrig's disease also known as familial amyotrophic lateral sclerosis (ALS). Approximately 20 percent of all familial ALS cases are...
Dynavax Technologies Corporation (NASDAQ: DVAX) announced initiation of a large-scale Phase 3 trial designed to demonstrate the lot-to-lot consistency of commercial vaccine and to complete the safety database for HEPLISAV™, the Company's investigational adult hepatitis B vaccine. This study and...
Pharmasset, Inc. (Nasdaq: VRUS) announces the initiation of a 28-day Phase 2a study with PSI-7977, a chirally pure isomer form of PSI-7851, a nucleotide analog polymerase inhibitor in development for the treatment of chronic hepatitis C (HCV). The trial will evaluate various doses of PSI-7977 in...
Pharmasset, Inc. (Nasdaq: VRUS) announces the initiation of a 28-day Phase 2a study with PSI-7977, a chirally pure isomer form of PSI-7851, a nucleotide analog polymerase inhibitor in development for the treatment of chronic hepatitis C (HCV). The trial will evaluate various doses of PSI-7977 in...